• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLFLEX COLONIC SOFT STENT SYSTEM WITH ANCHOR LOCK DELIVERY SYSTEM; STENT, COLONIC, METALIC, EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLFLEX COLONIC SOFT STENT SYSTEM WITH ANCHOR LOCK DELIVERY SYSTEM; STENT, COLONIC, METALIC, EXPANDABLE Back to Search Results
Device Problems Use of Device Problem (1670); Migration (4003)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 11/16/2023
Event Type  Injury  
Manufacturer Narrative
Block b3: the exact date of event was not reported.The article published date is used for the estimated date of event.Block d4, h4: the literature article did not provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.Block g2: literature source: walayat, s., et al."outcomes of colon self-expandable metal stents for malignant vs benign indications at a tertiary care center and review of literature".World j gastrointest endosc 2023; 15(4): 309-318.Doi: 10.4253/wjge.V15.I4.309.Block h6: imdrf device code a010402 captures the reportable event of stent migration.
 
Event Description
Boston scientific corporation became aware of the following event through the article, "outcomes of colon self-expandable metal stents for malignant vs benign indications at a tertiary care center and review of literature", by walayat, s., et al.Per the literature, a retrospective reviewed was performed to all patient who underwent colonic self-expanding metal stent placement from (b)(6) 2004 through (b)(6) 2022 at university of wisconsin.There were sixty-three patients over the age of 18 who underwent colonic stent placement.Fifty-five cases were for malignant indication, and eight were for benign conditions.The benign strictures included diverticular disease stricturing (n = 4), fistula closure (n = 2), extrinsic fibroid compression (n = 1), and ischemic stricture (n = 1).Forty-three of the malignant cases were due to intrinsic obstruction from primary or recurrent colon cancer; 12 were from extrinsic compression.Fifty-four strictures occurred on the left side, 3 occurred on the right and the rest in transverse colon.According to the literature, a case of a 55-year-old, female, was successfully implanted with a wallflex colonic stent for fistula closure at the sigmoid colon.However, post stent placement, the stent had migrated.
 
Manufacturer Narrative
Block b3: the exact date of event was not reported.The article published date is used for the estimated date of event.Block d4, h4: the literature article did not provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.Block g2: literature source: walayat, s., et al."outcomes of colon self-expandable metal stents for malignant vs benign indications at a tertiary care center and review of literature".World j gastrointest endosc 2023; 15(4): 309-318.Doi: 10.4253/wjge.V15.I4.309 block h6: imdrf device code a010402 captures the reportable event of stent migration.Block h11: correction to the initial mdr in blocks b5 and h6 (device code).
 
Event Description
Boston scientific corporation became aware of the following event through the article, "outcomes of colon self-expandable metal stents for malignant vs benign indications at a tertiary care center and review of literature", by walayat, s., et al.Per the literature, a retrospective reviewed was performed to all patient who underwent colonic self-expanding metal stent placement from august 2004 through august 2022 at university of wisconsin.There were sixty-three patients over the age of 18 who underwent colonic stent placement.Fifty-five cases were for malignant indication, and eight were for benign conditions.The benign strictures included diverticular disease stricturing (n = 4), fistula closure (n = 2), extrinsic fibroid compression (n = 1), and ischemic stricture (n = 1).Forty-three of the malignant cases were due to intrinsic obstruction from primary or recurrent colon cancer; 12 were from extrinsic compression.Fifty-four strictures occurred on the left side, 3 occurred on the right and the rest in transverse colon.According to the literature, a case of a 55-year-old, female, was successfully implanted with a wallflex colonic stent for fistula closure at the sigmoid colon.However, post stent placement, the stent had migrated.Note: it was reported that the wallflex colonic stent was implanted for a benign indication of treating a fistula.However, per the wallflex colonic soft stent system with anchor lock delivery system instructions for use, the stent is indicated for palliative treatment of colonic strictures caused by malignant neoplasms and to relieve large bowel obstructions prior to colectomy in patients with malignant strictures.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX COLONIC SOFT STENT SYSTEM WITH ANCHOR LOCK DELIVERY SYSTEM
Type of Device
STENT, COLONIC, METALIC, EXPANDABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key18603201
MDR Text Key334036409
Report Number3005099803-2024-00190
Device Sequence Number1
Product Code MQR
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/29/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/08/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age55 YR
Patient SexFemale
-
-